Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called REOLYSIN® for the treatment of solid tumors and hematological malignancies.

Biotechnology

Oncolytics Biotech

Matt Coffey

Richard Trauger

Mary Ann Dillahunty

Amy Levin

Kirk Look

Thomas C. Heineman

Allison Hagerman

The executive team at Oncolytics Biotech has a history of working in accounting and law. They have experience working at companies such as Ernst & Young LLP. They have degrees from universities such as Seton Hall University School of Law and the University of Calgary.

CEO and Executive Team

Board of Directors

Leadership Team

CEO and Executive Team

About

Team members

Other teams at Oncolytics Biotech

Board of Directors

Leadership Team